Full Breakdown
Robert F. Kennedy Jr. Defends Trump's Drug Pricing Claims Amid Controversy
4/24/2026, 1:00:27 AM
Senate Hearing Highlights Miscalculations in Drug Pricing
During a Senate Finance Committee hearing on April 22, 2026, Health and Human Services Secretary Robert F. Kennedy Jr. defended President Donald Trump's claims regarding the TrumpRx drug discount program, which purportedly reduced prescription drug prices by as much as 600%. Kennedy's defense came in response to questioning from Senator Elizabeth Warren, who highlighted discrepancies in Trump's assertions about drug pricing.
Kennedy stated, "President Trump has a different way of calculating percentages. If you have a $600 drug and you reduce it to $10, that’s a 600% reduction." However, this assertion has been widely criticized as mathematically incorrect. A reduction from $600 to $10 actually represents a discount of approximately 98.33%, not 600%. Critics have pointed out that any discount exceeding 100% would imply that companies are paying consumers to take their products, a notion that is not feasible in standard economic terms.
Reactions and Criticism
The hearing drew significant media attention, with late-night host Jimmy Kimmel mocking Kennedy's defense of Trump's math. Kimmel quipped, "Who are you going to believe, [Trump] or math?" He also expressed concern over Kennedy's health, noting his audible breathing difficulties during the hearing, which have been attributed to his condition, spasmodic dysphonia. Kimmel remarked, “You understand, our secretary of health is dying before our eyes, and no one is doing anything about it.”
The public reaction to Kennedy's comments has been mixed. Some individuals have criticized the administration's handling of drug pricing, while others have defended Kennedy's attempt to support Trump's narrative. Online discussions have ranged from disbelief at the mathematical errors to debates about the significance of the actual savings versus the rhetoric used to describe them.
Official Statements & Responses
Senator Elizabeth Warren emphasized the absurdity of Trump's claims during the hearing, stating, “Six hundred percent, which I think means companies should be paying you to take their drugs.” This sentiment reflects a broader skepticism regarding the Trump administration's approach to drug pricing and transparency.
Despite the backlash, Trump has continued to assert that drug prices have been significantly lowered, stating as recently as March 25, 2026, that “We have lowered the price of drugs by 50, 60, 70 and 80 and 90 percent,” while also suggesting that the figures could be interpreted in various ways, including “400, 500, 600, 700 percent.”
Conflicting Reports & Gaps
While Kennedy's defense of Trump's claims has been met with widespread criticism, there is a notable divide in public perception. Some commentators argue that the focus should be on the actual savings provided by the TrumpRx program, regardless of the mathematical inaccuracies. Others contend that the misrepresentation of data undermines public trust in government claims about healthcare reforms.
Verbatim Quotes
- “President Trump has a different way of calculating percentages. If you have a $600 drug and you reduce it to $10, that's a 600% reduction.” — Robert F. Kennedy Jr., Secretary of Health and Human Services
- “Six hundred percent, which I think means companies should be paying you to take their drugs.” — Elizabeth Warren, U.S. Senator
- “Who are you going to believe, [Trump] or math? Have you ever bankrupted a casino? I don’t think so.” — Jimmy Kimmel, Talk Show Host
As the debate over drug pricing continues, the implications of these discussions extend beyond mere arithmetic, raising questions about the integrity of public health policy and the communication strategies employed by government officials.
